EP0695346A1 - Humane blutbildende vorläuferzellpopulation - Google Patents

Humane blutbildende vorläuferzellpopulation

Info

Publication number
EP0695346A1
EP0695346A1 EP94913419A EP94913419A EP0695346A1 EP 0695346 A1 EP0695346 A1 EP 0695346A1 EP 94913419 A EP94913419 A EP 94913419A EP 94913419 A EP94913419 A EP 94913419A EP 0695346 A1 EP0695346 A1 EP 0695346A1
Authority
EP
European Patent Office
Prior art keywords
cells
population
progenitor cells
cell
erythroid progenitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94913419A
Other languages
English (en)
French (fr)
Inventor
James G. Bender
Dennis E. Van Epps
Kristen L. Unverzagt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of EP0695346A1 publication Critical patent/EP0695346A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
EP94913419A 1993-04-23 1994-04-14 Humane blutbildende vorläuferzellpopulation Withdrawn EP0695346A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5243393A 1993-04-23 1993-04-23
PCT/US1994/004124 WO1994025571A1 (en) 1993-04-23 1994-04-14 Human erythroid progenitor cell population
US52433 1998-03-31

Publications (1)

Publication Number Publication Date
EP0695346A1 true EP0695346A1 (de) 1996-02-07

Family

ID=21977580

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94913419A Withdrawn EP0695346A1 (de) 1993-04-23 1994-04-14 Humane blutbildende vorläuferzellpopulation

Country Status (6)

Country Link
EP (1) EP0695346A1 (de)
JP (1) JPH08509377A (de)
AU (1) AU6559094A (de)
CA (1) CA2160871A1 (de)
IL (1) IL106255A0 (de)
WO (1) WO1994025571A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399249B2 (en) 2008-02-21 2013-03-19 Baxter International Inc. Procedure for the generation of a high producer cell line for the expression of a recombinant anti-CD34 antibody

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47041A1 (en) * 1992-03-23 1998-03-20 Bender James G In vitro-derived human neutrophil precursor cells
AU9508998A (en) * 1997-09-25 1999-04-12 Glycotech Corp. Methods and compositions for binding hematopoietic stem cells
AU2333999A (en) * 1998-01-23 1999-08-09 Prolifaron, Inc. Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
WO2007010941A1 (ja) * 2005-07-20 2007-01-25 Kaneka Corporation 抗原及びこの抗原を識別するモノクローナル抗体
JP2010516239A (ja) 2007-01-18 2010-05-20 スオメン プナイネン リスティ，ヴェリパルベル 細胞の産生に対する新規方法および試薬
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6633522B2 (ja) 2013-11-16 2020-01-22 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
JP2019000063A (ja) * 2017-06-19 2019-01-10 東ソー株式会社 未分化細胞の剥離回収方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL54911A0 (en) * 1978-06-15 1978-08-31 Yeda Res & Dev Process for the fractionation of cells
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5081030A (en) * 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9425571A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399249B2 (en) 2008-02-21 2013-03-19 Baxter International Inc. Procedure for the generation of a high producer cell line for the expression of a recombinant anti-CD34 antibody

Also Published As

Publication number Publication date
WO1994025571A1 (en) 1994-11-10
AU6559094A (en) 1994-11-21
JPH08509377A (ja) 1996-10-08
IL106255A0 (en) 1993-11-15
CA2160871A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
Brandt et al. Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.
US5672346A (en) Human stem cell compositions and methods
Baer et al. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis
Sawada et al. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin.
Strife et al. Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells
Rabellino et al. Membrane receptors of mouse leukocytes. II. Sequential expression of membrane receptors and phagocytic capacity during leukocyte differentiation
US6241984B1 (en) Human hematopoietic progenitor cell preparations and their expansion in a liquid medium
US5541103A (en) CD34+ peripheral blood progenitor cells obtained by ex vivo expansion
EP0695346A1 (de) Humane blutbildende vorläuferzellpopulation
Pistoia et al. Large granular lymphocytes have a promoting activity on human peripheral blood erythroid burst-forming units
EP1553832B1 (de) Zusammensetzungen und verfahren zur trennung von zellen
Lowenberg et al. Further results in understanding the subpopulation structure of AML: clonogenic cells and their progeny identified by differentiation markers
US5955357A (en) In-vitro-derived human neutrophil precursor cells
Zimmerman et al. Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applications
Havenith et al. Separation of alveolar macrophages and dendritic cells via autofluorescence: phenotypical and functional characterizatior
Mazur et al. Isolation of large numbers of enriched human megakaryocytes from liquid cultures of normal peripheral blood progenitor cells
Harrison et al. Separation of haemopoietic cells for biochemical investigation. Preparation of erythroid and myeloid cells from human and laboratory-animal bone marrow and the separation of erythroblasts according to their state of maturation
Vainchenker et al. Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome.
Visani et al. Membrane receptors for interleukin 2 on hematopoietic precursors in chronic myeloid leukemia
FRITSCH et al. Does cord blood contain enough progenitor cells for transplantation?
US5888499A (en) Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
ALMICI et al. Counterflow centrifugal elutriation: experimental and clinical applications
Bacigalupo et al. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF
Pierelli et al. Purified unfractionated G‐CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor
PRETI et al. The combined use of soybean agglutinin and immunomagnetic beads for T lymphocyte subset depletion of bone marrow allografts: a laboratory analysis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951030

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

17Q First examination report despatched

Effective date: 19970528

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19971011